| Literature DB >> 35911589 |
Salomé Le Franc1,2, Gabriela Herrera Altamira3, Maud Guillen2,4, Simon Butet1,5, Stéphanie Fleck3,6, Anatole Lécuyer2, Laurent Bougrain3, Isabelle Bonan1,5.
Abstract
Stroke is a severe health issue, and motor recovery after stroke remains an important challenge in the rehabilitation field. Neurofeedback (NFB), as part of a brain-computer interface, is a technique for modulating brain activity using on-line feedback that has proved to be useful in motor rehabilitation for the chronic stroke population in addition to traditional therapies. Nevertheless, its use and applications in the field still leave unresolved questions. The brain pathophysiological mechanisms after stroke remain partly unknown, and the possibilities for intervention on these mechanisms to promote cerebral plasticity are limited in clinical practice. In NFB motor rehabilitation, the aim is to adapt the therapy to the patient's clinical context using brain imaging, considering the time after stroke, the localization of brain lesions, and their clinical impact, while taking into account currently used biomarkers and technical limitations. These modern techniques also allow a better understanding of the physiopathology and neuroplasticity of the brain after stroke. We conducted a narrative literature review of studies using NFB for post-stroke motor rehabilitation. The main goal was to decompose all the elements that can be modified in NFB therapies, which can lead to their adaptation according to the patient's context and according to the current technological limits. Adaptation and individualization of care could derive from this analysis to better meet the patients' needs. We focused on and highlighted the various clinical and technological components considering the most recent experiments. The second goal was to propose general recommendations and enhance the limits and perspectives to improve our general knowledge in the field and allow clinical applications. We highlighted the multidisciplinary approach of this work by combining engineering abilities and medical experience. Engineering development is essential for the available technological tools and aims to increase neuroscience knowledge in the NFB topic. This technological development was born out of the real clinical need to provide complementary therapeutic solutions to a public health problem, considering the actual clinical context of the post-stroke patient and the practical limits resulting from it.Entities:
Keywords: brain plasticity; brain–computer interface; motor rehabilitation; neurofeedback; stroke
Year: 2022 PMID: 35911589 PMCID: PMC9332194 DOI: 10.3389/fnhum.2022.917909
Source DB: PubMed Journal: Front Hum Neurosci ISSN: 1662-5161 Impact factor: 3.473
FIGURE 1Description of the Neurofeedback loop. NFB, neurofeedback; EEG, electroencephalography; fMRI, functional magnetic resonance imaging; NIRS, near infrared spectroscopy; MEG, magnetoencephalography.
FIGURE 2Physiological recovery mechanism in brain motor areas after stroke. Increasing activity of the non-affected side motor-related areas at the acute recovery phase (A). Non-affected side brain motor area activity decreased in the first months after stroke onset (B). Brain motor area activity in the affected side increases after 6 months (C). SMA, supplementary motor area; PM, premotor area; M1, primary motor area.
FIGURE 3Evolution of NFB studies in the literature. Number of NFB studies in stroke population according to the time since the stroke. The studies included in the graph are those cited in the main meta-analyses since 2018 (Carvalho et al., 2019; Bai et al., 2020; Kruse et al., 2020; Baniqued et al., 2021). (A) Acute phase. (B) Subacute phase. (C) Chronic phase.
Summary of acquisition systems and their specificities used in NFB studies in post-stroke context.
| EEG | fMRI | fNIRS | MEG | |
| Principle | Measures the differences in electric potential between electrodes on the scalp. | Measures the blood-oxygen-level-dependent (BOLD) contrast: a change in magnetization between oxygen-rich and oxygen-poor blood correlated with neuronal activity. | Measures changes in the infrared light absorption between oxy-hemoglobin and deoxyhemoglobin from blood vessels on the surface of the brain. | Captures the magnetic fields generated by the movements of ions induced by the activity of neurons. |
| Biomarkers | ERD/ERS | BOLD in the ROI | HbO value | ERD/ERS |
| Spatial resolution | 20 mm | 1 mm | 10 mm | 15 mm |
| Temporal resolution | 1 ms | 1 s | <1 s | 1 ms |
| No | Metalic implantable medical devices | No | No | |
| Targets | Cortical | Cortical or deep | Cortical | Cortical |
| Estimated installation time | About 15–20 min | 1–10 min | 1–5 min | 1–5 min |
| Tolerability | ++++ | ++ | ++++ | +++ |
| Side effects | No | No | No | No |
| Portability | Yes | No | Yes | No |
| Use in clinical practice | ++++ | ++ | + | + |
| Technical difficulties | Artifacts, movement | Artifacts, movement | Artifacts, movement | Artifacts, movement |
| Technical mastery | Requires trained personnel | Requires trained personnel | ||
| Equipment cost | 100 – 20,000 euros | 1–5 million + 300 euros per hour | 15,000 euros | 2 millions |
ERD, event-related desynchronization; ERS, event-related synchronization; HbO, oxygenated hemoglobin; HbR, deoxygenated hemoglobin; ROI, region of interest. Coupling of numerical methods for the forward problem in Magneto- and Electro-Encephalography (
Summary of types of feedback versus the time since stroke, lesion location, type of stroke, measurements employed for the clinical assessment, signal acquisition system, and features used for classifications.
| Type of feedback | Study | Time since stroke | Lesion location | Type of stroke | Measurements for clinical assessment | Signal acquisition system | Features | |||
|
|
|
| Ischemic | Hemorrhagic | ||||||
| Visual |
| ✓ | Unilateral, cortical, subcortical, or mixed stroke | ✓ | ✓ | FMA-UE, MRC, NIHSS, upper limb section of the MAS for spasticity | EEG | Band Power | ||
|
| ✓ | NI | NI | NI | ARAT, NHPT, GS, McI | EEG | Band Power | |||
|
| ✓ | Subcortical (Putamen, Corona radiata) | ✓ | ✓ | FMA-UE, ARAT, MAL, KVIQ-10 | NIRS | Band Power | |||
|
| ✓ | NI | NI | NI | JHFT | EEG | Band Power | |||
| Immersive Virtual Reality |
| ✓ | Subcortical | NI | NI | FMA-UE, MAS, SIS | EEG | Band Power | ||
| Functional Electrical Stimulation |
| ✓ | NI | ✓ | ✓ | TUG, BBS | EEG | Band Power | ||
|
| ✓ | Middle cerebral artery | ✓ | ✓ | FMA-UE, Stroke Impact Scale | EEG | Band Power | |||
|
| ✓ | NI | NI | NI | Shoulder subluxation: vertical distance, horizontal distance. | EEG | Band Power | |||
|
| ✓ | NI | ✓ | ✓ | FMA-UE, MAL, MBI, ROM of paretic arm | EEG | Band Power | |||
|
| ✓ | Subcortical, Cortical | ✓ | ✓ | FMA-UE, MRC | EEG | Band Power | |||
| Exoskeleton |
| ✓ | Subcortical, Cortical | ✓ | ✓ | ARAT, MAS | EEG | Band Power | ||
|
| ✓ | Subcortical, Cortical | NI | NI | FMA-UE | EEG | Band Power | |||
| Robot |
| ✓ | ✓ | NI | ✓ | ✓ | FMA-UE | EEG | Band Power | |
|
| ✓ | Subcortical, Cortical | ✓ | ✓ | FMA-UE, ARAT, JHFT, pinch and grip strengths | EEG | Band Power | |||
NI, no information was provided by the authors; FMA-UE, Fugl-Meyer Assessment for upper extremity; MRC, Medical Research Council scale for muscle strength; NIHSS, National Institute of Health Stroke Scale; MAS, Modified Ashworth Scale; ARAT, Action Research Arm Test; NHPT, Nine Hole Peg Test; GS, grip strength; McI, upper limb movement and motor control: Motricity Index; MAL, Motor Activity Log; KVIQ, Kinesthetic and Visual Imagery Questionnaire; JHFT, Jebsen Hand Function Test; TUG, Timed Up-and-Go test; BBS, Berg Balance Scale; MBI, Modified Barthel Index; ROM, Range Of Motion; SIS, Stroke Impact Scale.
Properties to take into consideration while selecting the feedback nature for a post-stroke subject.
| Visual | Virtual reality | Haptic | ||||
|
|
|
|
|
| ||
|
| ||||||
| Portability | Possible | Possible | Possible | Not possible | Possible | Possible |
| Adaptability | Yes/High | Yes/High | Yes/High | Low | Medium | Yes/High |
| Experienced operator | Not needed | Maybe | Not indispensable | Yes | Depends on the complexity of the device | Yes |
| Financial Investment | Medium | High | Medium | High | High, some low-cost approaches possible | High |
|
| ||||||
| Spasticity | Might affect | Depends on severity | Might affect | |||
| Severe aphasia | – | – | – | – | – | – |
| Severe ataxia | Might affect | Might affect | – | – | – | |
| Metal implants | – | |||||
| Pacemakers | – | |||||
| Skin injuries or diseases | Might affect | – | ||||
| Visual impairment | – | – | – | |||
| Seizures | – | – | – | – | – | – |
| Severe hemineglect | – | – | – | – | – | – |
| Severe arthritis | – | – | – | |||
| Cognitive Impairment | – | – | – | – | – | – |
The “–” symbol means that the presence of the clinical limitation minimizes the possibility of using the feedback modality.
FIGURE 4Clinical, electrophysiological, pathophysiological, and material parameters to be taken into account in an NFB study.